USFDA classifies Wanbury’s 2 manufacturing facilities as acceptable

Wanbury’s manufacturing facilities situated at Patalganga and Tanaku have been classified as acceptable by the Department of Health & Human Services, Public Health Service, Food and Drug Administration, USA (USFDA).

Wanbury’s major thrust area lies in Active Pharmaceutical Ingredient (API) and Contract Research and Manufacturing Services (CRAMS). It has a presence in Spain through its branded formulation business - Cantabria Pharma S. L acquired in 2006.